Recent drug approvals for the treatment of relapsed/refractory multiple myeloma
Monoclonal antibodies and checkpoint inhibitors for multiple myeloma
Immunotherapy for multiple myeloma: current research avenues
Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.
What do current multiple myeloma clinical trials have in common?